Circulating proinflammatory cytokines and N-terminal pro-brain natriuretic peptide significantly decrease with recovery of left ventricular function in patients with dilated cardiomyopathy

Molecular and Cellular Biochemistry

Volumn 324, Issue 1-2, 2009, Pages 139-145

  Ahmad, Shamim ^a   Otaal, Parminder Singh ^a   Rai, Taranjit Singh ^a   Bahl, Ajay ^a   Saikia, Uma Nahar ^a   Manoj, Rohit K ^a   Thungapathra, M ^a   Talwar, Kewal K ^a   Khullar, Madhu ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Dilated cardiomyopathy; LVEF recovery; Nt proBNP; Proinflammatory cytokines

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CYTOKINE; GLYCOPROTEIN GP 130; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; CYTOKINE RECEPTOR GP130; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR FUNCTION, LEFT; YOUNG ADULT;

EID: 61549119444     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9992-1     Document Type: Article

References (34)

1. Richardson P, McKenna W, Bristow M et al (1996) Report of the 1995 world health organization/international society and federation of cardiology task force on the definition and classification of cardiomyopathies. Circulation 93:841-842
2. Torre-Amione G, Kapadia S, Lee J et al (1996) Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 93:704-711
3. Natanson C, Eichenholz PW, Danner RL et al (1989) Endotoxin and tumor necrosis factor challenges in dogs stimulate the cardiovascular profile of human septic shock. J Exp Med 169:823-832. doi: 10.1084/jem.169.3.823
4. Mann DL, Young JB (1994) Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest 105:897-904. doi: 10.1378/chest.105.3.897
5. Seta Y, Shan K, Bozkurt B, Oral H, Mann OL (1996) Basic mechanisms in heart failure: The cytokine hypothesis. J Card Fail 2:243-249. doi: 10.1016/S1071-9164(96)80047-9
6. Paulus WJ (1999) How are cytokines activated in heart failure? Eur J Heart Fail 1:309-312. doi: 10.1016/S1388-9842(99)00049-5
7. Yamauchi-Takihara K, Ihara Y, Ogata A (1995) Hypoxic stress induces cardiac myocyte-derived interleukin-6. Circulation 91:1520-1524
8. Hirota H, Yoshida K, Kishimoto T, Taga T (1995) Continuous activation of gp130, a signal-transducing receptor component for interleukin-6 related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci USA 92:4862-4866. doi: 10.1073/pnas.92.11.4862
9. Cappellin E, Gatti R, Spinella P et al (2001) Plasma atrial natriuretic peptide (ANP) fragments proANP (1-30) and proANP (31-67) measurements in chronic heart failure: A useful index for heart transplantation? Clin Chim Acta 310:49-52. doi: 10.1016/S0009-8981(01)00520-4
10. Hammemer-Lercher A, Neubauer E, Muller S, Pachinger O, Puschendorf B, Mair J (2001) Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta 310:193-197. doi: 10.1016/S0009-8981(01)00578-2
11. Ishii J, Nomura M, Ito M et al (2000) Plasma concentration of brain natriuretic peptide as a biochemical marker for the evaluation of right ventricular overload and mortality in chronic respiratory disease. Clin Chim Acta 301:19-30. doi: 10.1016/S0009-8981(00)00312-0
12. Bettencourt P, Frioes F, Azevedo A et al (2004) Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure. Int J Cardiol 93:45-48. doi: 10.1016/S0167-5273(03)00115-3
13. Gardner RS, Ozalp F, Murday AJ, Robb SD, McDonagh TA (2003) N-terminal probrain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 24:1735-1743. doi: 10.1016/j.ehj.2003.07.005
14. Latini R, Masson S, Anand I et al (2004) The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J 25:292-299. doi: 10.1016/ j.ehj.2003.10.030
15. Bozkurt B, Kribbs S, Clubb FJ Jr et al (1998) Pathophysiologically relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97:1382-1391
16. Thaik CM, Calderone A, Takahashi N, Colucci WS (1995) Interleukin-1, modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest 96:1093-1099. doi: 10.1172/JCI118095
17. Kubota T, McTiernan CF, Frye CS et al (1997) Dilated cardiomyopathy in transgenic mice with cardiac specific overexpression of tumor necrosis factor-α. Circ Res 81:627-635
18. Dutka DP, Elborn JS, Delamere F, Shale DJ, Morris GK (1993) Tumor necrosis factor in severe congestive heart failure. Br Heart J 70:141-143. doi: 10.1136/hrt.70.2.141
19. Neumann FJ, Ott I, Gawaz M et al (1995) Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92:748-755
20. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL (1996) Proinflammatory cytokines levels in patients with depressed left ventricular ejection fraction: A report from the SOLVD study. J Am Coll Cardiol 27:1201-1206. doi: 10.1016/0735-1097(95)00589-7
21. Chang H, Chung J, Choi B et al (2003) The origin of proinflammatory cytokines in patients with idiopathic dilated cardiomyopathy. J Korean Med Sci 18:791-796
22. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D (1992) Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175:323-329. doi: 10.1084/jem.175.2.323
23. Ferrari R, Bachetti T, Confortini R et al (1995) Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92:1479-1486
24. Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D (1995) Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur J Haematol 54:1-8
25. Levine B, Kalman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323:236-241
26. Bristow MR (1998) Tumor necrosis factor-alpha and cardiomyopathy. Circulation 97:1340-1341
27. Kelly RA, Smith TW (1997) Cytokines and cardiac contractile function. Circulation 95:778-781
28. Aukrust P, Ueland T, Lien E et al (1999) Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 83:376-382. doi: 10.1016/ S0002-9149(98)00872-8
29. Feldman AM, Combes A, Wagner D et al (2000) The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 35:537-544. doi: 10.1016/S0735-1097(99)00600-2
30. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M (1998) Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 135:825-832. doi: 10.1016/ S0002-8703(98)70041-9
31. Sudoh T, Maekawa K, Kojima M, Minamino N, Kangawa K, Matsuo H (1989) Cloning and sequence analysis of cDNA encoding as a precursor for human brain natriuretic peptide. Biochem Biophys Res Commun 159:1427-1434. doi: 10.1016/0006-291X(89)92269-9
32. Pudil R, Tichy M, Praus R, Balaha V, Vojacek J (2007) NT-proBNP and echocardia parameters in patients with acute heart disease. Acta Medica (Cordoba) 50(1):51-56
33. Asbun J, Villarreal FJ (2006) The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol 47(4):693-700. doi: 10.1016/j.jacc.2005.09.050
34. Westermann D, Van Linthout S, Dhayat S et al (2007) Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy. Basic Res Cardiol 102:500-507. doi: 10.1007/s00395-007-0673-0